Kemp Proteins Establishes a Strategic Partnership with NeuImmune to Implement the geCHO Technology to Advance Precision Protein Production

PartnershipPositive

AI Analysis

Summary

Kemp Proteins established a strategic partnership with NeuImmune to implement geCHO (glycoengineered CHO) technology for precision protein production and cell line development capabilities.

Importance:6/10

Sentiment:

0.60

partnershipcell line developmentprotein productionglycoengineeringCHO technology

Related Companies

$DTIL

Read the original article

Published by PR Newswire Pharma on September 17, 2026 6:45 PM

Read Original